Acumen Pharmaceuticals Shows Early Alzheimer’s Disease Insights
By Daniella Parra Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) said its Enhanced Brain Delivery (EBD) bispecific antibodies showed improved brain penetration in the treatment of Alzheimer’s disease....
